TRIUMPH-3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
May 2024 — Vol. 1, No. 5
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, May 2024Janoshik result on a Suzhou tirzepatide lot lands 4.1 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 23-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
SWB declines, for the 4th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a HJ orforglipron lot at 95.8%, against 93.6% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A shortage listing ends. 11 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
PIONEER 6 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Argentina declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Hangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
SGN declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
VendorInvestigate result on a Zhuhai survodutide lot lands 0.9 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What a 21% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What the new Saudi Arabia guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Japan health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
STEP 3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Turkey pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.